Literature DB >> 6219974

Lung vessel leak precedes right ventricular hypertrophy in monocrotaline-treated rats.

T Sugita, T M Hyers, I M Dauber, W W Wagner, I F McMurtry, J T Reeves.   

Abstract

Monocrotaline induces microvascular leak and pulmonary hypertension in rats. We have hypothesized that the leak is related in some way to the pulmonary hypertension and precedes it. In rats given 40 mg monocrotaline/kg body wt subcutaneously, lung wet weight-to-dry weight ratios and lung albumin content began to increase within the first 3 days and became maximal at 1 wk. Alveolar lavage fluid showed little or no increase in protein. Right ventricular hypertrophy increased progressively from 2 through 3 wk. An increase in lung dry weight paralleled the right ventricular hypertrophy. The amount of blood retained in the lung did not account for the increased lung water, albumin, or weight. We considered that microvascular leak without leak into the alveolar space preceded pulmonary hypertension, right ventricular hypertrophy, and increased lung dry weight. In rats not given monocrotaline but exposed for 3 wk to hypobaric hypoxia, lung albumin, lung dry weight, and right ventricular weight increased. Increased lung dry weight probably reflects hyperplasia of lung cells. If so, an association of microvascular leak, lung cell hyperplasia, and right ventricular hypertrophy may occur in both monocrotaline- and hypoxia-induced pulmonary hypertension.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6219974     DOI: 10.1152/jappl.1983.54.2.371

Source DB:  PubMed          Journal:  J Appl Physiol Respir Environ Exerc Physiol        ISSN: 0161-7567


  16 in total

1.  Beneficial effects of trimetazidine on mitochondrial function and superoxide production in the cardiac muscle.

Authors:  C Guarnieri; C Muscari
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

2.  Disruption of lineage specification in adult pulmonary mesenchymal progenitor cells promotes microvascular dysfunction.

Authors:  Christa F Gaskill; Erica J Carrier; Jonathan A Kropski; Nathaniel C Bloodworth; Swapna Menon; Robert F Foronjy; M Mark Taketo; Charles C Hong; Eric D Austin; James D West; Anna L Means; James E Loyd; W David Merryman; Anna R Hemnes; Stijn De Langhe; Timothy S Blackwell; Dwight J Klemm; Susan M Majka
Journal:  J Clin Invest       Date:  2017-05-02       Impact factor: 14.808

3.  Hypoxia-induced increases in pulmonary transvascular protein escape in rats. Modulation by glucocorticoids.

Authors:  T J Stelzner; R F O'Brien; K Sato; J V Weil
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

4.  Effect of monocrotaline ingestion on the distribution of protein and angiotensin converting enzyme activity in the rat lung.

Authors:  D J Shale; M S Wiseman; W O Cookson
Journal:  Thorax       Date:  1986-12       Impact factor: 9.139

5.  C-type natriuretic peptide does not attenuate the development of pulmonary hypertension caused by hypoxia and VEGF receptor blockade.

Authors:  Brian Casserly; Jeffrey M Mazer; Alexander Vang; Elizabeth O Harrington; James R Klinger; Sharon Rounds; Gaurav Choudhary
Journal:  Life Sci       Date:  2011-07-27       Impact factor: 5.037

6.  Bosentan attenuates right ventricular hypertrophy and fibrosis in normobaric hypoxia model of pulmonary hypertension.

Authors:  Gaurav Choudhary; Frederick Troncales; Douglas Martin; Elizabeth O Harrington; James R Klinger
Journal:  J Heart Lung Transplant       Date:  2011-05-08       Impact factor: 10.247

7.  Hypoxemia and elevated tachykinins in rat monocrotaline pneumotoxicity.

Authors:  Y L Lai; A A Thacker; J N Diana
Journal:  Lung       Date:  1996       Impact factor: 2.584

8.  Endothelial hyperpermeability in severe pulmonary arterial hypertension: role of store-operated calcium entry.

Authors:  Chun Zhou; Mary I Townsley; Mikhail Alexeyev; Norbert F Voelkel; Troy Stevens
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-07-15       Impact factor: 5.464

9.  PAF receptor blockade inhibits lung vascular changes in the rat monocrotaline model.

Authors:  S Ono; N F Voelkel
Journal:  Lung       Date:  1992       Impact factor: 2.584

10.  Protection by oestradiol against the development of cardiovascular changes associated with monocrotaline pulmonary hypertension in rats.

Authors:  M Y Farhat; M F Chen; T Bhatti; A Iqbal; S Cathapermal; P W Ramwell
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.